Literature DB >> 27571697

Viral interactions with components of the splicing machinery.

F Meyer1.   

Abstract

Eukaryotic genes are often interrupted by stretches of sequence with no protein coding potential or obvious function. After transcription, these interrupting sequences must be removed to give rise to the mature messenger RNA. This fundamental process is called RNA splicing and is achieved by complicated machinery made of protein and RNA that assembles around the RNA to be edited. Viruses also use RNA splicing to maximize their coding potential and economize on genetic space, and use clever strategies to manipulate the splicing machinery to their advantage. This article gives an overview of the splicing process and provides examples of viral strategies that make use of various components of the splicing system to promote their replicative cycle. Representative virus families have been selected to illustrate the interaction with various regulatory proteins and ribonucleoproteins. The unifying theme is fine regulation through protein-protein and protein-RNA interactions with the spliceosome components and associated factors to promote or prevent spliceosome assembly on given splice sites, in addition to a strong influence from cis-regulatory sequences on viral transcripts. Because there is an intimate coupling of splicing with the processes that direct mRNA biogenesis, a description of how these viruses couple the regulation of splicing with the retention or stability of mRNAs is also included. It seems that a unique balance of suppression and activation of splicing and nuclear export works optimally for each family of viruses.
Copyright © 2016 Elsevier Inc. All rights reserved.

Keywords:  SR protein; alternative splicing; hnRNP; mRNA nuclear export; snRNP; splicing; viruses

Mesh:

Year:  2016        PMID: 27571697     DOI: 10.1016/bs.pmbts.2016.05.008

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  7 in total

1.  Reovirus μ2 protein modulates host cell alternative splicing by reducing protein levels of U5 snRNP core components.

Authors:  Simon Boudreault; Mathieu Durand; Carole-Anne Martineau; Jean-Pierre Perreault; Guy Lemay; Martin Bisaillon
Journal:  Nucleic Acids Res       Date:  2022-05-20       Impact factor: 19.160

2.  A genetic screen implicates a CWC16/Yju2/CCDC130 protein and SMU1 in alternative splicing in Arabidopsis thaliana.

Authors:  Tatsuo Kanno; Wen-Dar Lin; Jason L Fu; Antonius J M Matzke; Marjori Matzke
Journal:  RNA       Date:  2017-04-03       Impact factor: 4.942

Review 3.  Viral modulation of cellular RNA alternative splicing: A new key player in virus-host interactions?

Authors:  Simon Boudreault; Patricia Roy; Guy Lemay; Martin Bisaillon
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-04-29       Impact factor: 9.957

Review 4.  Unconventional RNA-binding proteins step into the virus-host battlefront.

Authors:  Manuel Garcia-Moreno; Aino I Järvelin; Alfredo Castello
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-08-09       Impact factor: 9.957

5.  Discovery and Characterization of an Aberrant Small Form of Glycoprotein I of Herpes Simplex Virus Type I in Cell Culture.

Authors:  Xixi Gui; Wuchao Zhang; Peng Gao; Yongning Zhang; Lei Zhou; Xinna Ge; Xin Guo; John W Wills; Jun Han; Hanchun Yang
Journal:  Microbiol Spectr       Date:  2022-03-29

6.  PRP4KA, a Putative Spliceosomal Protein Kinase, Is Important for Alternative Splicing and Development in Arabidopsis thaliana.

Authors:  Tatsuo Kanno; Peter Venhuizen; Tuan-Nan Wen; Wen-Dar Lin; Phebe Chiou; Maria Kalyna; Antonius J M Matzke; Marjori Matzke
Journal:  Genetics       Date:  2018-10-08       Impact factor: 4.562

7.  Betacoronavirus-specific alternate splicing.

Authors:  Guy Karlebach; Bruce Aronow; Stephen B Baylin; Daniel Butler; Jonathan Foox; Shawn Levy; Cem Meydan; Christopher Mozsary; Amanda M Saravia-Butler; Deanne M Taylor; Eve Wurtele; Christopher E Mason; Afshin Beheshti; Peter N Robinson
Journal:  bioRxiv       Date:  2021-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.